DE69931100D1 - Verfahren zu Fabrikation von Alpha 1l-Adrenorezeptor Antagonisten - Google Patents
Verfahren zu Fabrikation von Alpha 1l-Adrenorezeptor AntagonistenInfo
- Publication number
- DE69931100D1 DE69931100D1 DE69931100T DE69931100T DE69931100D1 DE 69931100 D1 DE69931100 D1 DE 69931100D1 DE 69931100 T DE69931100 T DE 69931100T DE 69931100 T DE69931100 T DE 69931100T DE 69931100 D1 DE69931100 D1 DE 69931100D1
- Authority
- DE
- Germany
- Prior art keywords
- fabrication
- alpha
- adrenoreceptor antagonists
- fluoro
- chem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title abstract 3
- 229940082496 Adrenoreceptor antagonist Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7997498P | 1998-03-30 | 1998-03-30 | |
| US79974P | 1998-03-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69931100D1 true DE69931100D1 (de) | 2006-06-08 |
| DE69931100T2 DE69931100T2 (de) | 2007-04-19 |
Family
ID=22153993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69931100T Expired - Fee Related DE69931100T2 (de) | 1998-03-30 | 1999-03-22 | Verfahren zu Fabrikation von Alpha 1l-Adrenorezeptor Antagonisten |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6156894A (de) |
| EP (1) | EP0949250B1 (de) |
| JP (1) | JP3276342B2 (de) |
| KR (1) | KR100347469B1 (de) |
| CN (1) | CN1136199C (de) |
| AT (1) | ATE325104T1 (de) |
| CA (1) | CA2267510C (de) |
| DE (1) | DE69931100T2 (de) |
| DK (1) | DK0949250T3 (de) |
| ES (1) | ES2263238T3 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5127366B2 (ja) | 2007-08-29 | 2013-01-23 | 富士通コンポーネント株式会社 | 情報処理装置、ｋｖｍスイッチ、サーバ及び制御プログラム |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3867456A (en) * | 1965-07-30 | 1975-02-18 | Oreal | Mono-omega-haloalkyl amines |
| JPS5324952B2 (de) * | 1973-11-28 | 1978-07-24 | ||
| PT748800E (pt) * | 1995-06-09 | 2001-10-30 | Hoffmann La Roche | Derivados de pirimidinadiona pirimidinatriona triazinadiona como antagonistas do receptor alfa-1-adrenergico |
| US5859014A (en) * | 1995-06-09 | 1999-01-12 | Syntex (U.S.A.) Inc. | Pyrimidinedione, pyrimidinetrione, triazinedione and tetrahydroquinazolinedione derivatives as α1 -adrenergic receptor antagonists |
| HRP970239B1 (en) * | 1997-05-09 | 2004-04-30 | Inst Ru Er Bouekovic | Process for the preparation of sulfonyl-pyrimidine derivatives with antitumor activity |
-
1999
- 1999-03-22 AT AT99105755T patent/ATE325104T1/de not_active IP Right Cessation
- 1999-03-22 ES ES99105755T patent/ES2263238T3/es not_active Expired - Lifetime
- 1999-03-22 DE DE69931100T patent/DE69931100T2/de not_active Expired - Fee Related
- 1999-03-22 EP EP99105755A patent/EP0949250B1/de not_active Expired - Lifetime
- 1999-03-22 DK DK99105755T patent/DK0949250T3/da active
- 1999-03-24 US US09/275,333 patent/US6156894A/en not_active Expired - Fee Related
- 1999-03-29 CA CA002267510A patent/CA2267510C/en not_active Expired - Fee Related
- 1999-03-29 KR KR1019990010780A patent/KR100347469B1/ko not_active IP Right Cessation
- 1999-03-29 JP JP08508899A patent/JP3276342B2/ja not_active Expired - Fee Related
- 1999-03-30 CN CNB991045041A patent/CN1136199C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2267510A1 (en) | 1999-09-30 |
| EP0949250B1 (de) | 2006-05-03 |
| KR100347469B1 (ko) | 2002-08-07 |
| JP3276342B2 (ja) | 2002-04-22 |
| CN1136199C (zh) | 2004-01-28 |
| JPH11322724A (ja) | 1999-11-24 |
| CA2267510C (en) | 2005-05-17 |
| ATE325104T1 (de) | 2006-06-15 |
| DE69931100T2 (de) | 2007-04-19 |
| DK0949250T3 (da) | 2006-08-28 |
| EP0949250A1 (de) | 1999-10-13 |
| KR19990078360A (ko) | 1999-10-25 |
| ES2263238T3 (es) | 2006-12-01 |
| CN1234398A (zh) | 1999-11-10 |
| US6156894A (en) | 2000-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY138525A (en) | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | |
| DE69901717D1 (de) | Phosphohalohydrine, verfahren zu deren herstellung und verwendungen | |
| DE69703935D1 (de) | 2-chloro-3,5-bis(trifluoromethyl)phenyl-benzoylharnstoff-derivate und verfahren zur herstellung derselben | |
| ATE266030T1 (de) | 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen | |
| DE69231815D1 (de) | Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren | |
| DE60235365D1 (de) | Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung | |
| DE59910677D1 (de) | Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen | |
| DE60228724D1 (de) | Verfahren zur herstellung von beraprost und dessen salzen | |
| DE69931100D1 (de) | Verfahren zu Fabrikation von Alpha 1l-Adrenorezeptor Antagonisten | |
| DE60224884D1 (de) | Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen | |
| DE60219950D1 (de) | Verfahren zur überwachung/bekämpfung von thysanoptera | |
| ATE106397T1 (de) | Verfahren zur herstellung von 3,3- diarylacrylsäureamiden. | |
| NZ333229A (de) | ||
| DE69529499T2 (de) | Stereoselektives Verfahren zur Herstellung von Dihydro-2,3-benzodiazepin-Derivaten | |
| DE69737376D1 (de) | Verfahren zur Synthese einer Oxonolverbindung | |
| ATE480512T1 (de) | Verfahren zur herstellung einer epoxytriazolverbindung und zwischenprodukt dafür | |
| DK0662475T3 (da) | Fremgangsmåde til fremstilling af 2-perfluoralkyl-3-oxazolin-5-on. | |
| ATE258165T1 (de) | Verfahren und zwischenverbindungen zur herstellung von 1-(9h-carbazol-4-yloxy)-3-(2-(2- methoxy-phenoxy)-ethylamino)-propan-2-ol, carvediol, oder ein säureadditionssalz davon | |
| ATE277914T1 (de) | Verfahren zur herstellung von 1,4,7,10- tetraazacyclododecan | |
| ATE311382T1 (de) | Verfahren zur herstellung von 2-carbamoyl- pyridinen | |
| DE69837628D1 (de) | Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel | |
| ATE286058T1 (de) | Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung | |
| DE69208008D1 (de) | Verfahren zur Herstellung von 2-Amino-5,6-Dimethoxy Tetralin | |
| ATE215561T1 (de) | Methylsulfomycin 1, verfahren zu dessen herstellung und verwendung | |
| DE60218774D1 (de) | Verfahren zur Herstellung von N,N-carbonyl diimidazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |